Baxter International, Inc. (BAX)
23.80
-0.38
(-1.57%)
USD |
NYSE |
Sep 11, 16:00
23.81
+0.01
(+0.04%)
Pre-Market: 20:00
Baxter International Net Income (Quarterly) : 135.00M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 135.00M |
| March 31, 2026 | -17.00M |
| December 31, 2025 | -1.035B |
| September 30, 2025 | -51.00M |
| June 30, 2025 | 122.00M |
| March 31, 2025 | 64.00M |
| December 31, 2024 | -488.00M |
| September 30, 2024 | 61.00M |
| June 30, 2024 | 95.00M |
| March 31, 2024 | 6.00M |
| December 31, 2023 | 219.00M |
| September 30, 2023 | 37.00M |
| June 30, 2023 | -193.00M |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 144.00M |
| September 30, 2022 | -2.991B |
| June 30, 2022 | 185.00M |
| March 31, 2022 | 73.00M |
| December 31, 2021 | 242.00M |
| September 30, 2021 | 452.00M |
| June 30, 2021 | 301.00M |
| March 31, 2021 | 300.00M |
| December 31, 2020 | 171.00M |
| September 30, 2020 | 359.00M |
| June 30, 2020 | 247.00M |
| Date | Value |
|---|---|
| March 31, 2020 | 333.00M |
| December 31, 2019 | -19.00M |
| September 30, 2019 | 375.00M |
| June 30, 2019 | 313.00M |
| March 31, 2019 | 342.00M |
| December 31, 2018 | 311.00M |
| September 30, 2018 | 518.00M |
| June 30, 2018 | 343.00M |
| March 31, 2018 | 389.00M |
| December 31, 2017 | -61.00M |
| September 30, 2017 | 248.00M |
| June 30, 2017 | 264.00M |
| March 31, 2017 | 273.00M |
| December 31, 2016 | 240.00M |
| September 30, 2016 | 127.00M |
| June 30, 2016 | 1.212B |
| March 31, 2016 | 3.387B |
| December 31, 2015 | 183.00M |
| September 30, 2015 | 2.00M |
| June 30, 2015 | 74.00M |
| March 31, 2015 | 134.00M |
| December 31, 2014 | 127.00M |
| September 30, 2014 | 175.00M |
| June 30, 2014 | 468.00M |
| March 31, 2014 | 507.00M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Becton, Dickinson & Co. | 451.00M |
| DexCom, Inc. | 249.10M |
| Boston Scientific Corp. | 905.00M |
| West Pharmaceutical Services, Inc. | 154.00M |
| Abbott Laboratories | 928.00M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 2.96B |
| Total Expenses (Quarterly) | 2.825B |
| EPS Diluted (Quarterly) | 0.2432 |
| Enterprise Value | 18.98B |
| Gross Profit Margin (Quarterly) | 33.55% |
| Profit Margin (Quarterly) | 4.56% |
| Earnings Yield | -8.10% |
| Operating Earnings Yield | 5.26% |
| Normalized Earnings Yield | -1.729 |